A recent study has demonstrated that upregulation of serum CXCL16 levels in patients with rheumatoid arthritis-associated pulmonary fibrosis stimulates proliferation, migration, and collagen production of fibroblasts via the PI3K/AKT/FOXO3a pathway (Ma et al. 2020). Here, FOXO3 is linked to pulmonary fibrosis.